Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz
BEDMINSTER, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ITCI), a biopharmaceutical company focused on the development ...